effects [qlco]
Low dose [qnco]
Oral [spco]
Transdermal [ftcn]
Estrogen Replacement Therapy [topp]
haemostatic [ortf]
Health [idcn]
postmenopausal [tmco]
Women [popg]
randomized [resa]
placebo controlled study [inpr, resa]
Objective [inpr]
Study [mnob]
investigate [ftcn]
Transdermal [ftcn]
Oral [spco]
Estrogen Replacement Therapy [topp]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Marker [clna]
Coagulation [ortf]
Fibrinolysis [phsf]
coronary artery disease [dsyn]
Study Design [resa]
randomized [resa]
placebo controlled study [inpr, resa]
DOUBLE BLIND [resa]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Received [qlco]
Daily [tmco]
placebo [topp]
N NOS [aapp, imft]
Transdermal [ftcn]
17beta estradiol [horm, phsu, strd]
Te [elii, hops]
Group [idcn]
N NOS [aapp, imft]
Oral [spco]
mg% [qnco]
Oe [qnco]
Group [idcn]
N NOS [aapp, imft]
Oral [spco]
mg% [qnco]
Combined [qlco]
Gestodene [phsu, strd]
Oe [qnco]
Group [idcn]
N NOS [aapp, imft]
treatment [ftcn]
Cycle [tmco]
haemostatic [ortf]
variables [qlco]
Measured [qlco]
blood samples [bdsu]
Collected [idcn]
baseline [bodm]
Cycle [tmco]
baseline [bodm]
placebo [topp]
Te [elii, hops]
Group [idcn]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
Cycle [tmco]
P NOS [aapp, imft]
Oe [qnco]
Group [idcn]
Percentage [qnco]
baseline [bodm]
placebo [topp]
Cycle [tmco]
Fibrinogen [aapp, bacs, phsu]
P NOS [aapp, imft]
Factor VII [aapp, bacs, phsu]
P NOS [aapp, imft]
Thrombin-antithrombin complex [aapp, enzy]
III [inpr]
P NOS [aapp, imft]
Tissue-Type Plasminogen Activator [aapp, enzy, phsu]
P NOS [aapp, imft]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
P NOS [aapp, imft]
Oe [qnco]
Group [idcn]
Factor VII [aapp, bacs, phsu]
P NOS [aapp, imft]
Plasminogen Activator [aapp, enzy, phsu]
P NOS [aapp, imft]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
P NOS [aapp, imft]
D-dimer [aapp, bacs]
P NOS [aapp, imft]
Observed [ftcn]
Prothrombin fragment 1+2 [aapp, bacs]
Plasmin [aapp, enzy, phsu]
alpha-2-Antiplasmin [aapp, bacs, phsu]
Complexes [chvs]
Low estradiol [fndg]
Dose [qnco]
Oral [spco]
therapy [ftcn]
Fibrinolysis [phsf]
Small [qnco]
decreases [qnco]
Procoagulant [aapp, bacs]
variables [qlco]
Transdermal [ftcn]
therapy [ftcn]
Minor [popg]
effects [qlco]
